
Asher Bio
ActiveWe build better immunotherapies
This company has previously operated under βAsher Biotherapeuticsβ, βAsher Biotherapeuticsβ, βAsher Bioβ, βAsher Biotherapeuticsβ. A rename frequently marks a pivot in positioning or product β useful raw material for variant ideas.
About
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
Founders Β· 2
Related startups

Arpeggio Bio develops drugs targeting transcription factors using AIβ¦

We solve drug resistance for cancer


